From study to action

The DAWN study provided a blueprint of what it means to live with diabetes and what challenges healthcare providers are facing in their efforts to help their patients control and manage their condition effectively. With these conclusive insights about critical needs and gaps, the DAWN study has proven itself an important platform for dialogue and partnerships and as a decision making tool to improve outcomes of diabetes care.

Novo Nordisk has so far organized three large international DAWN Summits, in 2002, 2003 and 2006, to set the stage for concerted advocacy and action.

The 3rd International DAWN summit, which was held in Florence, Italy, gathered 900 diabetes experts, people with diabetes, policy-makers and professionals from 64 countries to set the stage for large-scale initiatives to improve treatment outcomes through patient-centred self-management and psychosocial support strategies. Read more about the 3rd DAWN Summit here

Through the DAWN programme, Novo Nordisk promotes new partnerships to truly translate DAWN into action.

For DAWN references - please go to DAWN publications